Last €76.89 EUR
Change Today +0.07 / 0.09%
Volume 2.4M
SAN On Other Exchanges
Symbol
Exchange
EN Paris
EN Paris
New York
OTC US
BrsaItaliana
Mexico
Frankfurt
Frankfurt
NASDAQ GM
As of 11:35 AM 07/30/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Christopher A. Viehbacher

Chief Executive Officer, Director and Member of Strategy Committee, Sanofi
AgeTotal Calculated CompensationThis person is connected to 44 board members in 5 different organizations across 9 different industries.

See Board Relationships
54€8,648,326
As of Fiscal Year 2013

Background*

Mr. Christopher A. Viehbacher, also known as Chris, serves as the Chairman and Chief Executive Officer of Sanofi-Aventis ADS. He is the Chief Executive Officer of Sanofi-Aventis at BiPar Sciences, Inc. Mr. Viehbacher has been the Chief Executive Officer of Sanofi-Aventis S.A. (Spain) since December 1, 2008. He serves as the Chief Executive Officer of Sanofi-Aventis S A France. He has been the Chief Executive Officer of Sanofi (also known as Sanofi-Aventis) since December ...

Read Full Background

Corporate Headquarters*

54, Rue La Boétie
Paris, Ile-de-France 75008

France

Phone: 33 1 53 77 40 00
Fax: --

Board Members Memberships*

Chairman and Chief Executive Officer of Sanofi
Chairman
Chairman
President of the Board
2008-2008
Former President of North American Pharmaceuticals, Member of Financial Results Committee and Member of Corporate Administration & Transactions Committee
2008-Present
Chief Executive Officer, Director and Member of Strategy Committee

Education*

Unknown/Other Education
Queen's University

Other Affiliations*

Annual Compensation*

Salary€1,260,000
Bonus€1,701,000
Total Annual Compensation€2,961,000

Stock Options*

Restricted Stock Awards€2,798,550
All Other Compensation€3,976
Exercisable Options250,000
Unexercisable Options1,055,000
Total Number of Options1,305,000

Total Compensation*

Total Annual Cash Compensation€2,964,976
Total Short Term Compensation€2,961,000
Other Long Term Compensation€2,802,526
Total Calculated Compensation€8,648,326
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
SAN:FP €76.89 EUR +0.07

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
John C. Martin Ph.D.Chairman and Chief Executive Officer
Gilead Sciences Inc.
$1.6M
Marijn E. Dekkers Ph.D.Chairman of Management Board and Chief Executive Officer
Bayer AG
€2.9M
Andrew Philip Witty Chief Executive Officer, Executive Director, Member of Corporate Administration & Transactions Committee and Member of Finance Committee
GlaxoSmithKline plc
2.9M GBP
Kenneth C. Frazier Chairman and Chief Executive Officer
Merck & Co. Inc.
$1.5M
Lars Rebien Sørensen Chief Executive Officer
Novo Nordisk A/S
kr15.2M
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact SANOFI, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.